New Migraine Guidelines: Asia-Pacific Insights for Effective Care

Research Summary

A recent study published in Frontiers in Neurology explored how clinicians in the Asia-Pacific region diagnose and manage migraines, revealing insights from a Delphi consensus involving 14 headache specialists. The study reported that 93% of specialists use the ICHD-3 criteria for diagnosis, finding them easy to apply. Key symptoms such as neck pain and dizziness were recognized by 93% of respondents. Anti-CGRP mAbs were hailed as addressing unmet needs for migraine prevention by 86% of participants, with efficacy being the top priority in their selection. Specialists endorsed anti-CGRP mAbs for adolescents but advised against their use in younger children due to insufficient data.

Study Details

📄 Title: Delphi consensus on the real-world application of the updated diagnostic and treatment guidelines for migraine in Asia Pacific.

👥 Research Team: Siow CHC et al.

📚 Published In: Front Neurol

📅 Publication Date: 2026

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.